首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1392398

全球獸醫腫瘤市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Veterinary Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年11月01日 | 出版商:

Value Market Research | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球獸醫腫瘤市場的市場規模將從 2022 年的 3097.2 億美元達到近 10,248.2 億美元，2023-2030 年研究期間CAGR為 14.22%。

獸醫腫瘤學基本上是對患有癌症的寵物進行診斷和治療。狗和貓更容易患皮膚癌和骨癌等疾病。它使用傷害、飢餓、水合、衛生、幸福、行動量表來與寵物主人討論和確定他們的生活品質，然後再做出治療這些疾病的安樂死決定。導致寵物罹患癌症的因素包括動物皮膚持續暴露在陽光和外部環境下、病毒以及煙霧、殺蟲劑、紫外線和放射性廢物等致癌物質。

市場動態：

淋巴瘤、皮膚癌、肥大細胞癌等癌症疾病盛行率的增加導致對獸醫腫瘤學市場的高需求。越來越多的寵物收養和對寵物健康的日益關注正在激增對該市場的需求。用於評估腫瘤藥物安全性和有效性的獸醫臨床研究數量的增加正在促進對該市場的需求。此外，私人和政府組織對動物護理中心的資金增加以及寵物腫瘤治療研發活動的增加正在推動該市場的需求。此外，在研究期間，獸醫腫瘤治療領域主要製造公司的存在以及動物保健支出的增加也推動了市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球獸醫腫瘤學市場的每個細分市場進行了包容性評估。獸醫腫瘤學行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲獸醫腫瘤學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。獸醫腫瘤市場的主要參與者包括 PetCure Oncology、Zoetis Inc.、Karyopharm Therapeutics, Inc.、Varian Medical Systems、Accuray Incorporated、Boehringer Ingelheim GmbH、Elanco、One Health、Regeneus Ltd。競爭格局，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望銷售分析
簡介銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：獸醫腫瘤公司的競爭格局

獸醫腫瘤學市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

十大公司股票分析
市場集中度
PetCure Oncology

公司簡介
公司收入
產品
最近的發展

Zoetis Inc.

公司簡介
公司收入
產品
最近的發展

Karyopharm Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Varian Medical Systems

公司簡介
公司收入
產品
最近的發展

Accuray Incorporated

公司簡介
公司收入
產品
最近的發展

Boehringer Ingelheim GmbH

公司簡介
公司收入
產品
最近的發展

Elanco

公司簡介
公司收入
產品
最近的發展

One Health

公司簡介
公司收入
產品
最近的發展

Regeneus Ltd

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218350

The global demand for Veterinary Oncology Market is presumed to reach the market size of nearly USD 1024.82 BN by 2030 from USD 309.72 BN in 2022 with a CAGR of 14.22% under the study period 2023 - 2030.

Veterinary oncology is basically the diagnosis and treatment of pets suffering from cancer. Dogs and cats are more prone to develop diseases like skin cancer and bone cancer. It uses the Hurt Hunger Hydration Hygiene Happiness Mobility Scale to discuss and identify their quality of life with pet owners before making a euthanasia decision for the treatment of these diseases. Factors that lead to cancer in pets include constant exposure of animal skin to the sun and external environment, viruses, and carcinogens such as smoke, pesticides, UV light and radioactive waste.

MARKET DYNAMICS:

The increase in the prevalence of cancer diseases such as lymphoma, skin cancer, mast cell cancer etc. is leading to high demand for the veterinary oncology market. Rising pet adoption and a growing focus on pet health are surging the demand for this market. An increase in the number of veterinary clinical studies for evaluating the safety and efficiency of oncology drugs is fostering the demand for this market. In addition, an increase in funding from private & government organizations for animal care centres and a rise in R&D activities for oncology treatment in pets are boosting the demand for this market. Moreover, the presence of key manufacturing companies in veterinary oncology treatment and rise in animal healthcare expenditure is also propelling the market growth during the study.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary oncology. The growth and trends of veterinary oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the veterinary oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others

By Animal Type

Canine
Feline

By Cancer Type

Lymphoma
Mast Cell Cancer
Mammary And Squamous Cell Cancer
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Oncology market include PetCure Oncology, Zoetis Inc., Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . VETERINARY ONCOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapy
- 3.7.2 Market Attractiveness Analysis By Animal Type
- 3.7.3 Market Attractiveness Analysis By Cancer Type
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY

6.1 Overview by Therapy
6.2 Historical and Forecast Data
6.3 Analysis by Therapy
6.4 Surgery Historic and Forecast Sales by Regions
6.5 Radiotherapy Historic and Forecast Sales by Regions
6.6 Chemotherapy Historic and Forecast Sales by Regions
6.7 Immunotherapy Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

7.1 Overview by Animal Type
7.2 Historical and Forecast Data
7.3 Analysis by Animal Type
7.4 Canine Historic and Forecast Sales by Regions
7.5 Feline Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY CANCER TYPE

8.1 Overview by Cancer Type
8.2 Historical and Forecast Data
8.3 Analysis by Cancer Type
8.4 Lymphoma Historic and Forecast Sales by Regions
8.5 Mast Cell Cancer Historic and Forecast Sales by Regions
8.6 Mammary And Squamous Cell Cancer Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

10.1. Veterinary Oncology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. PetCure Oncology
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Zoetis Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Karyopharm Therapeutics Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Varian Medical Systems
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Accuray Incorporated
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Boehringer Ingelheim GmbH
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Elanco
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. One Health
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Regeneus Ltd
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments